Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amaking is a multi-ingredient herbal dietary supplement developed and manufactured by Bepharco (Ben Tre Pharmaceutical Joint Stock Company) in Vietnam. It is specifically formulated to support male vitality and address symptoms associated with male menopause and declining sexual health. The supplement contains a synergistic blend of traditional botanical extracts, including *Eurycoma longifolia* (Tongkat Ali) and *Tribulus terrestris*, alongside the amino acid L-Arginine and the mineral Zinc. *Eurycoma longifolia* is recognized for its potential to increase free testosterone levels by inhibiting sex hormone-binding globulin (SHBG), while *Tribulus terrestris* is traditionally used to enhance libido and physical performance. L-Arginine serves as a precursor to nitric oxide, which facilitates vasodilation and supports erectile function. Amaking is marketed as an over-the-counter product to improve overall physical strength and sexual well-being in men.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Amaking.